Blueshift Asset Management, LLC Enanta Pharmaceuticals Inc Transaction History

Blueshift Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$38.13 - $76.93 $18,302 - $36,926	-480 Reduced 9.84%	4,398 $208,000
Q1 2022 May 12, 2022	BUY	$56.06 - $74.11 $273,460 - $361,508	4,878 New	4,878 $347,000
Q3 2019 Nov 12, 2019	SELL	$60.08 - $88.17 $192,556 - $282,584	-3,205 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$81.3 - $97.35 $47,316 - $56,657	582 Added 22.19%	3,205 $270,000
Q1 2019 May 14, 2019	BUY	$69.08 - $105.66 $181,196 - $277,146	2,623 New	2,623 $251,000

110

21.1M

4.8K

4.6K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $194M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Blueshift Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Blueshift Asset Management, LLC with notifications on news.